Acumen, JCR partner to enhance Alzheimer’s therapy delivery
The partnership combines Acumen's expertise in amyloid beta oligomer-selective antibodies with JCR's blood-brain barrier-penetrating technology, to improve AD treatment delivery.
News
Sun Pharma launches Leqselvi in the US for severe alopecia areata
Bayer gets FDA approval for finerenone to treat heart failure with LVEF
ViiV Healthcare expands MPP licensing deal for long-acting HIV treatment
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs
Imugene’s azer-cel shows promise in treating relapsed DLBCL
Elegen, Nutcracker unveil cell-free RNA manufacturing pilot
CEL-SCI collaboration to advance Multikine access in Saudi Arabia
